On October 18, 2024, Procter & Gamble (P&G) released its first quarter financial results and conducted a conference call to discuss the performance. The company also provided informational slides on its website and filed a Form 8-K with the SEC, which included the slides as part of the Regulation FD Disclosure. P&G reported a 2% organic sales growth for the quarter, with varying performance across its business segments. The Beauty segment saw a 2% decrease, while Health Care experienced a 4% increase. The company's Core EPS for the quarter was $1.93, marking a 5% increase from the previous year's $1.83. Adjusted for currency impacts, the Currency-Neutral Core EPS was $1.91, a 4% increase. P&G's gross margin remained stable at 52.0%, and the Core Operating Margin...Show More

On October 18, 2024, Procter & Gamble (P&G) released its first quarter financial results and conducted a conference call to discuss the performance. The company also provided informational slides on its website and filed a Form 8-K with the SEC, which included the slides as part of the Regulation FD Disclosure. P&G reported a 2% organic sales growth for the quarter, with varying performance across its business segments. The Beauty segment saw a 2% decrease, while Health Care experienced a 4% increase. The company's Core EPS for the quarter was $1.93, marking a 5% increase from the previous year's $1.83. Adjusted for currency impacts, the Currency-Neutral Core EPS was $1.91, a 4% increase. P&G's gross margin remained stable at 52.0%, and the Core Operating Margin saw a slight increase of 30 basis points. The company's adjusted free cash flow productivity was 82%, with an adjusted free cash flow of $3.871 billion. P&G completed a limited market portfolio restructuring, primarily in Argentina, to address challenging conditions, which was reflected in the financial adjustments. The company's forward-looking guidance for FY 2025 estimates a net sales growth of 2% to 4%, with organic sales growth projected at 3% to 5%.